首页> 外国专利> HIGH-DENSITY LIPOPROTEIN, AND DELIVERY OF DRUG TO POSTERIOR SEGMENT OF EYE BY OCULAR INSTILLATION OF SAID CYTOPHILIC PEPTIDE-FUSED HIGH-DENSITY LIPOPROTEIN

HIGH-DENSITY LIPOPROTEIN, AND DELIVERY OF DRUG TO POSTERIOR SEGMENT OF EYE BY OCULAR INSTILLATION OF SAID CYTOPHILIC PEPTIDE-FUSED HIGH-DENSITY LIPOPROTEIN

机译:高密度脂蛋白和通过眼内注射速溶细胞肽融合的高密度脂蛋白将药物输送到眼的后半段

摘要

The purpose of the present invention is to provide a novel system for the delivery of a drug to a posterior segment of the eye. The present invention relates to: a cytophilic peptide-fused high-density lipoprotein (cHDL) which can be used as a carrier for the delivery of a drug to a posterior segment of the eye; a method for producing the cytophilic peptide-fused high-density lipoprotein; a system of the delivery of a drug to a posterior segment of the eye, a pharmaceutical composition, and a system of the delivery of a drug to a posterior segment of the eye, each of which utilizes the cytophilic peptide-fused high-density lipoprotein; and a method for diagnosing, preventing or treating posterior ocular disease.
机译:本发明的目的是提供一种用于将药物输送到眼睛的后段的新颖系统。本发明涉及:亲细胞肽融合的高密度脂蛋白(cHDL),其可用作将药物递送至眼后段的载体。一种亲细胞肽融合的高密度脂蛋白的生产方法;药物递送至眼后段的系统,药物组合物以及药物递送至眼后段的系统,每个系统均利用亲细胞肽融合的高密度脂蛋白;以及用于诊断,预防或治疗后眼疾病的方法。

著录项

  • 公开/公告号EP3238746A4

    专利类型

  • 公开/公告日2018-06-27

    原文格式PDF

  • 申请/专利权人 KYOTO UNIVERSITY;

    申请/专利号EP20150873258

  • 申请日2015-12-25

  • 分类号A61K47/42;A61K9/08;A61K9/127;A61K45;A61K47/24;A61P3/10;A61P9/10;A61P27/02;A61P27/06;A61P27/10;A61P27/12;A61P29;

  • 国家 EP

  • 入库时间 2022-08-21 13:17:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号